Thyroxine-binding globulin /TBG antibody
Principal name
Thyroxine-binding globulin /TBG antibody
Alternative names for Thyroxine-binding globulin /TBG antibody
T4-binding globulin, Serpin A7, SERPINA7
SwissProt ID
P05543 (Human), P35577 (Rat), P50450 (Sheep), P61939 (Mouse), Q9TT35 (Pig), Q9TT36 (Bovin)
Gene ID
6906 (SERPINA7)
Ncbi ID
Available reactivities
Available hosts
Available applications
Frozen Sections (C), Immunodiffusion (ID), Radioimmunoassay (R), Enzyme Immunoassay (E), ELISA (detection) (E(detection)), Western blot / Immunoblot (WB), Immunoprecipitation (IP), Immunocytochemistry/Immunofluorescence (ICC/IF), Paraffin Sections (P)
Background of Thyroxine-binding globulin /TBG antibody
- Kit Component:
- - KN204733G1, SERPINA7 gRNA vector 1 in pCas-Guide vector
- KN204733G2, SERPINA7 gRNA vector 2 in pCas-Guide vector
- KN204733D, donor vector containing left and right homologous arms and Luciferase-Puro functional cassette
- GE100003, scramble sequence in pCas-Guide vector - CRISPR Manual:
- CRISPR/CAS9 Genome Editing Manual

Western Blot analysis of SERPINA7 expression in transfected 293T cell line (H00006906-T01) by SERPINA7 MaxPab polyclonal antibody.Lane 1: SERPINA7 transfected lysate(46.30 KDa).Lane 2: Non-transfected lysate.

Thyroxine Binding Globulin antibody detects SERPINA7 protein at cytosol on hepatoma by immunohistochemical analysis. Sample: Paraffin-embedded hepatoma. Thyroxine Binding Globulin antibody (TA308829) dilution: 1:500.

Immunofluorescence analysis of paraformaldehyde-fixed HeLa, using TBG(TA308829) antibody at 1:200 dilution.

Formalin-fixed and paraffin-embedded human hepatocarcinoma reacted with SERPINA7 Antibody (C-term), which was peroxidase-conjugated to the secondary antibody, followed by DAB staining. This data demonstrates the use of this antibody for immunohistochemistry; clinical relevance has not been evaluated.

SERPINA7 Antibody (C-term) (Cat. #TA324862) flow cytometric analysis of MDA-MB231 cells (right histogram) compared to a negative control cell (left histogram).FITC-conjugated goat-anti-rabbit secondary antibodies were used for the analysis.
Primary Antibodies
| Catalog No. | Host | Iso. | Clone | Pres. | React. | Applications | |
|---|---|---|---|---|---|---|---|
| TA308829 | Thyroxine-binding globulin /TBG antibody |
||||||
| Rabbit polyclonal antibody to TBG (serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 7) | |||||||
![]() |
Rabbit | IgG | Aff - Purified | Hu | ICC/IF, P, WB |
0.1 ml /
$415.00
|
|
| OriGene Technologies, Inc. | |||||||
+2 additional images |
|||||||
| TA324862 | Thyroxine-binding globulin /TBG (C-term) antibody |
||||||
| Rabbit polyclonal SERPINA7 Antibody (C-term) | |||||||
![]() |
Rabbit | Hu | WB |
0.4 ml /
$415.00
|
|||
| OriGene Technologies, Inc. | |||||||
+2 additional images |
|||||||
| TA350501 | Thyroxine-binding globulin /TBG antibody |
||||||
| Rabbit Polyclonal Anti-SERPINA7 Antibody | |||||||
![]() |
Rabbit | IgG | Purified | Hu | E, P |
0.1 ml /
$335.00
|
|
| OriGene Technologies, Inc. | |||||||
| AP31579SU-N | Thyroxine-binding globulin /TBG antibody |
||||||
![]() |
Rabbit | Serum | Hu | R |
0.1 ml /
$500.00
|
||
| OriGene Technologies GmbH | |||||||
| AP31579SU-S | Thyroxine-binding globulin /TBG antibody |
||||||
![]() |
Rabbit | Serum | Hu | R |
20 µl /
$170.00
|
||
| OriGene Technologies GmbH | |||||||
Proteins & Growth Factors
| Catalog No. | Species | Pres. | Purity | Source | |
|---|---|---|---|---|---|
| TP304733 | Thyroxine-binding globulin /TBG |
||||
| Recombinant protein of human serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 7 (SERPINA7) | |||||
![]() |
Human | > 80 % Preparation: Recombint protein was captured through anti-DDK affinity column followed by conventiol chromatography steps. Purity Detail: > 80% as determined by SDS-PAGE and Coomassie blue staining. |
HEK293 cells |
20 µg /
$748.00
|
|
| OriGene Technologies, Inc. | |||||
Lysates
| Catalog No. | ||
|---|---|---|
| LY424772 | SERPINA7 overexpression lysate |
|
![]() |
0.1 mg /
$295.00
|
|
| OriGene Technologies, Inc. |




+2 additional images

